Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack F Wetzels

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Journal of the American Society of Nephrology : JASN|September 8, 2012
Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathyJulia M Hofstra, Hanna Debiec, Colin D Short, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 12, 2013
Time-averaged level of fibroblast growth factor-23 and clinical events in chronic kidney diseaseAnnet Bouma-de Krijger, Michiel L Bots, Marc G Vervloet, et al.
Journal of the American Society of Nephrology : JASN|November 26, 2004
Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation studyAmanda J W Branten, Peggy W du Buf-Vereijken, Ina S Klasen, et al.
Journal of the American Society of Nephrology : JASN|November 18, 2015
Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes InsipidusTheun de Groot, Anne P Sinke, Marleen L A Kortenoeven, et al.
Kidney International Reports|September 12, 2022
Diagnosis and Treatment of Patients With Focal Segmental Glomerulosclerosis/Steroid-Resistant Nephrotic Syndrome: A Delphi SurveyJürgen Floege, Keisha L Gibson, Manuel Praga, et al.
Clinical Kidney Journal|June 24, 2026
Executive summary of the European consensus report on the diagnosis and treatment of monoclonal gammopathy of renal significanceBen Sprangers, Camille Cohen, Viviane Gnemmi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 2, 2013
Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathyCornelia Dähnrich, Lars Komorowski, Christian Probst, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2019
Unraveling Hepcidin Plasma Protein Binding: Evidence from Peritoneal Equilibration TestingLaura E Diepeveen, Coby M Laarakkers, Hilde P E Peters, et al.
Proteomics|August 26, 2015
Increased expression of lysosome membrane protein 2 in glomeruli of patients with idiopathic membranous nephropathyIlse M Rood, Michael L Merchant, Daniel W Wilkey, et al.
Trials|April 12, 2014
Remote ischemic preconditioning to reduce contrast-induced nephropathy: study protocol for a randomized controlled trialThomas B Sterenborg, Theo P Menting, Yvonne de Waal, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Journal of the American Society of Nephrology : JASN|September 8, 2012
Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathyJulia M Hofstra, Hanna Debiec, Colin D Short, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 12, 2013
Time-averaged level of fibroblast growth factor-23 and clinical events in chronic kidney diseaseAnnet Bouma-de Krijger, Michiel L Bots, Marc G Vervloet, et al.
Journal of the American Society of Nephrology : JASN|November 26, 2004
Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation studyAmanda J W Branten, Peggy W du Buf-Vereijken, Ina S Klasen, et al.
Journal of the American Society of Nephrology : JASN|November 18, 2015
Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes InsipidusTheun de Groot, Anne P Sinke, Marleen L A Kortenoeven, et al.
Kidney International Reports|September 12, 2022
Diagnosis and Treatment of Patients With Focal Segmental Glomerulosclerosis/Steroid-Resistant Nephrotic Syndrome: A Delphi SurveyJürgen Floege, Keisha L Gibson, Manuel Praga, et al.
Clinical Kidney Journal|June 24, 2026
Executive summary of the European consensus report on the diagnosis and treatment of monoclonal gammopathy of renal significanceBen Sprangers, Camille Cohen, Viviane Gnemmi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 2, 2013
Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathyCornelia Dähnrich, Lars Komorowski, Christian Probst, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2019
Unraveling Hepcidin Plasma Protein Binding: Evidence from Peritoneal Equilibration TestingLaura E Diepeveen, Coby M Laarakkers, Hilde P E Peters, et al.
Proteomics|August 26, 2015
Increased expression of lysosome membrane protein 2 in glomeruli of patients with idiopathic membranous nephropathyIlse M Rood, Michael L Merchant, Daniel W Wilkey, et al.
Trials|April 12, 2014
Remote ischemic preconditioning to reduce contrast-induced nephropathy: study protocol for a randomized controlled trialThomas B Sterenborg, Theo P Menting, Yvonne de Waal, et al.
Pageof 6